Pulmonary function in Duchenne muscular dystrophy related to stage of disease

作者: Scott R. Inkley , Frederick C. Oldenburg , Paul J. Vignos

DOI: 10.1016/0002-9343(74)90611-1

关键词: Airway resistancePulmonary function testingInternal medicineCardiologyMedicineLung volumesHyperventilationOxygen tensionDuchenne muscular dystrophyRespiratory failureSurgeryHypoventilation

摘要: Abstract Thirty-eight patients with muscular dystrophy of the Duchenne type representing disease classification stages 2 through 9 were studied for changes in pulmonary function. Lung volumes, flow rates and airway resistance correlated maximal inspiratory expiratory pressure laboratory evidence muscle including serum aldolase creatine-creatinine excretion. When are grouped according to functional class, deterioration function pressures seems begin between class 5 6. In higher classes a reduction total lung capacity an increase residual volume is associated loss strength. Airway was normal all subjects whom it could be measured. Blood gases showed oxygen tension (pO ) subjects; one slight carbon dioxide (pCO ). Breathing per cent produced hyperventilation subjects. Pulmonary studies, particularly blood conjunction may significant help estimating prognosis determining intensity acute care infection or symptoms respiratory failure develop. Based on our clinical experience, pCO subject without extremely bad prognostic sign. After appropriate therapy, status hypoventilation often returns what before infection. Patients 8 below have good this regard.

参考文章(23)
John A. Sibley, Albert L. Lehninger, Determination of aldolase in animal tissues. Journal of Biological Chemistry. ,vol. 177, pp. 859- 872 ,(1949) , 10.1016/S0021-9258(18)57031-9
Leo F. Black, Robert E. Hyatt, Maximal respiratory pressures: normal values and relationship to age and sex. The American review of respiratory disease. ,vol. 99, pp. 696- 702 ,(1969) , 10.1164/ARRD.1969.99.5.696
E.J. Hapke, J.C. Meek, J. Jacobs, Pulmonary function in progressive muscular dystrophy. Chest. ,vol. 61, pp. 41- 47 ,(1972) , 10.1378/CHEST.61.1.41
Carl Schnell, Polymyositis Archives of Internal Medicine. ,vol. 114, pp. 263- 277 ,(1964) , 10.1001/ARCHINTE.1964.03860080113012
Paul J. Vignos, Management of Progressive Muscular Dystrophy of Childhood JAMA: The Journal of the American Medical Association. ,vol. 184, pp. 89- 96 ,(1963) , 10.1001/JAMA.1963.03700150043007
Jerome E. Neustadt, Robert C. Levy, I. Joshua Spiegel, Carbon Dioxide Narcosis in Association With Muscular Dystrophy JAMA. ,vol. 187, pp. 616- 617 ,(1964) , 10.1001/JAMA.1964.03060210066022
PJ V10N0S, J GOLDWYN, Evaluation of laboratory tests in diagnosis and management of polymyositis. The American Journal of the Medical Sciences. ,vol. 263, pp. 291- 308 ,(1972) , 10.1097/00000441-197204000-00012
A.P. Fishman, P. Samet, André Cournand, Ventilatory drive in chronic pulmonary emphysema The American Journal of Medicine. ,vol. 19, pp. 533- 548 ,(1955) , 10.1016/0002-9343(55)90345-4
William M. McCormack, Muscular Dystrophy, Alveolar Hypoventilation, and Papilledema JAMA: The Journal of the American Medical Association. ,vol. 197, pp. 957- 960 ,(1966) , 10.1001/JAMA.1966.03110120063015